SI1335908T1 - Agonisti peroksisomskega proliferator aktivirajoäśega receptorja alfa - Google Patents

Agonisti peroksisomskega proliferator aktivirajoäśega receptorja alfa

Info

Publication number: SI1335908T1
Authority: SI; Slovenia
Prior art keywords: activated receptor; receptor alpha; peroxisome proliferator; proliferator activated; alpha agonists
Prior art date: 2000-11-10

Application number

SI200130828T

Other languages

English (en)

Inventor

Nathan Bryan Mantlo

Cano Ivan Collado

Samuel James Dominianni

Garret Jay Junior Etgen

Cristina Garcia-Paredes

Richard Duane Johnston

Michael Edward Letourneau

Michael John Martinelli

Daniel Ray Mayhugh

Ashraf Saeed

Richard Craig Thompson

Xiadong Wang

David Scott Coffey

Christopher Randall Schmid

Jeffrey Thomas Vicenzi

Yanping Xu

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-10

Filing date

2001-11-09

Publication date

2008-08-31

2001-11-09 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2008-08-31 Publication of SI1335908T1 publication Critical patent/SI1335908T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/06—Compounds containing any of the groups, e.g. semicarbazides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/22—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having nitrogen atoms of amidino groups further bound to nitrogen atoms, e.g. hydrazidines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/02—Compounds containing any of the groups, e.g. carbazates
- C07C281/04—Compounds containing any of the groups, e.g. carbazates the other nitrogen atom being further doubly-bound to a carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Cultivation Of Plants (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SI200130828T 2000-11-10 2001-11-09 Agonisti peroksisomskega proliferator aktivirajoäśega receptorja alfa SI1335908T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US24731700P	2000-11-10	2000-11-10
PCT/US2001/042928 WO2002038553A2 (en)	2000-11-10	2001-11-09	Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists
EP01989704A EP1335908B1 (en)	2000-11-10	2001-11-09	Peroxisome proliferator activated receptor alpha agonists

Publications (1)

Publication Number	Publication Date
SI1335908T1 true SI1335908T1 (sl)	2008-08-31

Family

ID=22934453

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200130828T SI1335908T1 (sl)	2000-11-10	2001-11-09	Agonisti peroksisomskega proliferator aktivirajoäśega receptorja alfa

Country Status (34)

Country	Link
US (3)	US7304062B2 (sl)
EP (1)	EP1335908B1 (sl)
JP (1)	JP4243101B2 (sl)
KR (1)	KR100839705B1 (sl)
CN (1)	CN1479728A (sl)
AR (1)	AR031305A1 (sl)
AT (1)	ATE386026T1 (sl)
AU (3)	AU2002228592B8 (sl)
BR (1)	BR0114986A (sl)
CA (1)	CA2421154A1 (sl)
CY (1)	CY1107388T1 (sl)
CZ (1)	CZ20031283A3 (sl)
DE (1)	DE60132799T2 (sl)
DK (1)	DK1335908T3 (sl)
EA (1)	EA006920B1 (sl)
EC (1)	ECSP034595A (sl)
ES (1)	ES2300378T3 (sl)
HR (1)	HRP20030365A2 (sl)
HU (1)	HUP0301655A2 (sl)
IL (2)	IL154840A0 (sl)
MX (1)	MXPA03004141A (sl)
MY (1)	MY157884A (sl)
NO (1)	NO20032059L (sl)
NZ (1)	NZ524569A (sl)
PE (1)	PE20020693A1 (sl)
PL (1)	PL362692A1 (sl)
PT (1)	PT1335908E (sl)
SI (1)	SI1335908T1 (sl)
SK (1)	SK5412003A3 (sl)
SV (1)	SV2003000727A (sl)
TW (1)	TW200716572A (sl)
UA (1)	UA82048C2 (sl)
WO (1)	WO2002038553A2 (sl)
ZA (1)	ZA200302517B (sl)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002347985A1 (en) *	2001-11-15	2003-06-10	Eli Lilly And Company	Peroxisome proliferator activated receptor alpha agonists
GB0314079D0 (en) *	2003-06-18	2003-07-23	Astrazeneca Ab	Therapeutic agents
WO2004000789A1 (en)	2002-06-19	2003-12-31	Eli Lilly And Company	Amide linker peroxisome proliferator activated receptor modulators
TW200505441A (en)	2003-03-24	2005-02-16	Hoffmann La Roche	Non-nucleoside reverse transcriptase inhibitorsⅠ
FR2866339B1 (fr) *	2004-02-18	2006-05-05	Pf Medicament	Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine
US7262318B2 (en)	2004-03-10	2007-08-28	Pfizer, Inc.	Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) *	2004-06-29	2005-12-29	Pfizer Inc	Substituted heteroaryl- and phenylsulfamoyl compounds
US8293778B2 (en)	2004-07-27	2012-10-23	Roche Palo Alto Llc	Heterocyclic antiviral compounds
MX2007000788A (es) *	2004-07-27	2007-03-23	Hoffmann La Roche	Compuestos de benciltriazolona como inhibidores no nucleosidos de transcriptasa inversa.
KR100803481B1 (ko) *	2004-07-27	2008-02-14	에프. 호프만-라 로슈 아게	비-뉴클레오사이드 역전사효소 억제제로서의벤질트라이아졸론 화합물
AU2005272389B2 (en) *	2004-08-11	2011-08-04	Kyorin Pharmaceutical Co., Ltd.	Novel cyclic aminobenzoic acid derivative
WO2006068199A1 (ja) *	2004-12-22	2006-06-29	Mochida Pharmaceutical Co., Ltd.	代謝的に安定な３－オキシ－１，２，４－トリアゾール誘導体
TW200640453A (en) *	2005-01-28	2006-12-01	Lilly Co Eli	Formulations and dosing regimen for PPAR-α modulators
FR2882750B1 (fr) *	2005-03-03	2007-05-11	Pierre Fabre Medicament Sa	Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine
WO2006101108A1 (ja) *	2005-03-23	2006-09-28	Kyorin Pharmaceutical Co., Ltd.	新規環状アミノフェニルアルカン酸誘導体
WO2006099978A1 (en) *	2005-03-24	2006-09-28	F.Hoffmann-La Roche Ag	1,2,4-triazole-5-one compounds as heterocyclic reverse transcriptase inhibitors
JP5225076B2 (ja) *	2006-04-27	2013-07-03	田辺三菱製薬株式会社	チアゾール環を含むカルボン酸誘導体の医薬用途
WO2008103574A2 (en) *	2007-02-23	2008-08-28	Eli Lilly And Company	Peroxisome proliferator activated receptor modulators
EP2142520A1 (en)	2007-03-29	2010-01-13	F. Hoffmann-Roche AG	Non-nucleoside reverse transcriptase inhibitors
US8323360B2 (en) *	2008-06-30	2012-12-04	3M Innovative Properties Company	Method of crystallization
CN101643451B (zh) *	2008-08-07	2013-03-06	浙江海正药业股份有限公司	过氧化物酶增殖物激活受体亚型δ类激动剂化合物及其制备方法
KR101290868B1 (ko)	2008-12-01	2013-07-29	미쓰비시 타나베 파마 코퍼레이션	티아졸환을 포함하는 카르복실산 유도체 및 그의 의약 용도
US8575430B2 (en) *	2010-03-02	2013-11-05	Nunhems, B.V.	Hybrid artichoke variety NUN 4006 AR
US20110167512A1 (en) *	2009-03-02	2011-07-07	Nunhems B.V.	Hybrid artichoke variety nun 4006 ar
DE102010001064A1 (de) *	2009-03-18	2010-09-23	Bayer Schering Pharma Aktiengesellschaft	Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung
US20100245582A1 (en) *	2009-03-25	2010-09-30	Syclipse Technologies, Inc.	System and method of remote surveillance and applications therefor
US20130156720A1 (en)	2010-08-27	2013-06-20	Ironwood Pharmaceuticals, Inc.	Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US8648233B2 (en) *	2010-09-20	2014-02-11	Nunhems B.V.	Hybrid artichoke variety NUN 4021 AR
US8669420B2 (en)	2012-02-29	2014-03-11	Nunhems B.V.	Hybrid artichoke variety NUN 4060 AR
WO2013134562A1 (en)	2012-03-09	2013-09-12	Inception 2, Inc.	Triazolone compounds and uses thereof
JP6404230B2 (ja)	2012-12-20	2018-10-10	インセプション２、インコーポレイテッド	トリアゾロン化合物およびその使用
MX2016002795A (es) *	2013-09-06	2016-05-26	Inception 2 Inc	Compuestos de triazolona y usos de los mismos.
RU177130U1 (ru) *	2017-11-29	2018-02-09	Владимир Алексеевич Коннов	Плита изоляционная облицовочная
EP4135057A4 (en)	2020-04-10	2023-09-20	Panasonic Intellectual Property Management Co., Ltd.	THERMOELECTRIC TRANSDUCER, THERMOELECTRIC MODULE, BINDER AND METHOD FOR MANUFACTURING THERMOELECTRIC TRANSDUCER
CN112774869B (zh) *	2020-12-25	2022-09-16	厦门紫金矿冶技术有限公司	黄铁矿抑制剂及其制备和在铜铅锌多金属硫化矿中的应用
CN114853686B (zh) *	2021-08-23	2023-06-20	中国药科大学	三氮唑酮类化合物及其医药用途
CN115894379B (zh) *	2022-01-20	2025-06-27	哈尔滨三联药业股份有限公司	海因类化合物及其医药用途
CN114563394B (zh) *	2022-02-10	2025-03-11	湖南东方钪业股份有限公司	一种氟化钪中杂质含量的检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2090283A1 (en) *	1992-02-28	1993-08-29	Nobuyuki Hamanaka	Phenoxyacetic acid derivatives
US5641796A (en) *	1994-11-01	1997-06-24	Eli Lilly And Company	Oral hypoglycemic agents
DE19517505A1 (de) *	1995-05-12	1996-11-14	Bayer Ag	Sulfonylamino(thio)carbonyltriazolin(thi)one mit Aryloxy- oder Arylthio-Substituenten
EP0858457A1 (de) *	1995-10-20	1998-08-19	Dr. Karl Thomae GmbH	5-gliedrige heterocyclen, diese verbindungen enthaltende arzneimittel und deren verwendung sowie verfahren zu ihrer herstellung
AR017340A1 (es)	1997-10-17	2001-09-05	Astellas Pharma Inc	Un derivado de amida, su uso y una composicion farmaceutica que lo comprende.
CN1208326C (zh)	1998-04-23	2005-06-29	雷迪实验室有限公司	杂环化合物及其在医药方面的应用、其制备方法及含有它们的药物组合物
GB9914977D0 (en)	1999-06-25	1999-08-25	Glaxo Group Ltd	Chemical compounds
PE20011010A1 (es)	1999-12-02	2001-10-18	Glaxo Group Ltd	Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
US6573287B2 (en)	2001-04-12	2003-06-03	Bristo-Myers Squibb Company	2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
USPP14578P2 (en) *	2002-09-23	2004-03-09	Plant Sciences, Inc.	Artichoke plant named ‘PS-MSC0003’

2001
- 2001-09-11 UA UA2003054187A patent/UA82048C2/uk unknown
- 2001-11-07 AR ARP010105214A patent/AR031305A1/es unknown
- 2001-11-08 TW TW095138799A patent/TW200716572A/zh unknown
- 2001-11-08 PE PE2001001108A patent/PE20020693A1/es not_active Application Discontinuation
- 2001-11-08 MY MYPI20015155A patent/MY157884A/en unknown
- 2001-11-09 JP JP2002541088A patent/JP4243101B2/ja not_active Expired - Fee Related
- 2001-11-09 SV SV2001000727A patent/SV2003000727A/es not_active Application Discontinuation
- 2001-11-09 NZ NZ524569A patent/NZ524569A/en unknown
- 2001-11-09 MX MXPA03004141A patent/MXPA03004141A/es active IP Right Grant
- 2001-11-09 CN CNA018185878A patent/CN1479728A/zh active Pending
- 2001-11-09 DE DE60132799T patent/DE60132799T2/de not_active Expired - Fee Related
- 2001-11-09 EP EP01989704A patent/EP1335908B1/en not_active Expired - Lifetime
- 2001-11-09 DK DK01989704T patent/DK1335908T3/da active
- 2001-11-09 ES ES01989704T patent/ES2300378T3/es not_active Expired - Lifetime
- 2001-11-09 US US10/415,673 patent/US7304062B2/en not_active Expired - Fee Related
- 2001-11-09 KR KR1020037006301A patent/KR100839705B1/ko not_active Expired - Fee Related
- 2001-11-09 PL PL01362692A patent/PL362692A1/xx unknown
- 2001-11-09 EA EA200300558A patent/EA006920B1/ru not_active IP Right Cessation
- 2001-11-09 WO PCT/US2001/042928 patent/WO2002038553A2/en not_active Ceased
- 2001-11-09 HR HR20030365A patent/HRP20030365A2/hr not_active Application Discontinuation
- 2001-11-09 AU AU2002228592A patent/AU2002228592B8/en not_active Ceased
- 2001-11-09 AU AU2859202A patent/AU2859202A/xx active Pending
- 2001-11-09 IL IL15484001A patent/IL154840A0/xx unknown
- 2001-11-09 SK SK541-2003A patent/SK5412003A3/sk not_active Application Discontinuation
- 2001-11-09 AT AT01989704T patent/ATE386026T1/de not_active IP Right Cessation
- 2001-11-09 BR BR0114986-5A patent/BR0114986A/pt not_active IP Right Cessation
- 2001-11-09 SI SI200130828T patent/SI1335908T1/sl unknown
- 2001-11-09 CA CA002421154A patent/CA2421154A1/en not_active Abandoned
- 2001-11-09 CZ CZ20031283A patent/CZ20031283A3/cs unknown
- 2001-11-09 PT PT01989704T patent/PT1335908E/pt unknown
- 2001-11-09 HU HU0301655A patent/HUP0301655A2/hu unknown
2003
- 2003-03-10 IL IL154840A patent/IL154840A/en active IP Right Grant
- 2003-03-31 ZA ZA200302517A patent/ZA200302517B/en unknown
- 2003-05-08 NO NO20032059A patent/NO20032059L/no unknown
- 2003-05-08 EC EC2003004595A patent/ECSP034595A/es unknown
2006
- 2006-06-29 AU AU2006202811A patent/AU2006202811A1/en not_active Abandoned
2007
- 2007-07-26 US US11/828,446 patent/US20090062358A1/en not_active Abandoned
2008
- 2008-04-10 CY CY20081100391T patent/CY1107388T1/el unknown
- 2008-06-27 US US12/215,466 patent/US7868225B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
PT1335908E (pt)	2008-05-08
UA82048C2 (uk)	2008-03-11
PL362692A1 (en)	2004-11-02
CA2421154A1 (en)	2002-05-16
HUP0301655A2 (hu)	2003-12-29
NO20032059L (no)	2003-06-24
EA200300558A1 (ru)	2004-02-26
ZA200302517B (en)	2004-06-30
NO20032059D0 (no)	2003-05-08
MXPA03004141A (es)	2003-08-19
EP1335908A2 (en)	2003-08-20
WO2002038553A3 (en)	2003-05-01
AR031305A1 (es)	2003-09-17
AU2002228592B8 (en)	2006-08-24
JP4243101B2 (ja)	2009-03-25
PE20020693A1 (es)	2002-08-05
US20090044299A1 (en)	2009-02-12
ATE386026T1 (de)	2008-03-15
US7868225B2 (en)	2011-01-11
BR0114986A (pt)	2003-09-23
SK5412003A3 (en)	2004-01-08
MY157884A (en)	2016-08-01
HK1058790A1 (en)	2004-06-04
EA006920B1 (ru)	2006-04-28
CY1107388T1 (el)	2012-12-19
IL154840A0 (en)	2003-10-31
DE60132799D1 (de)	2008-03-27
ECSP034595A (es)	2003-06-25
US20090062358A1 (en)	2009-03-05
US20040102500A1 (en)	2004-05-27
AU2006202811A1 (en)	2006-07-20
DK1335908T3 (da)	2008-06-02
AU2002228592B2 (en)	2006-04-27
NZ524569A (en)	2006-05-26
HRP20030365A2 (en)	2003-08-31
DE60132799T2 (de)	2009-03-19
CZ20031283A3 (cs)	2003-09-17
SV2003000727A (es)	2003-01-13
AU2859202A (en)	2002-05-21
IL154840A (en)	2009-09-22
KR100839705B1 (ko)	2008-06-19
EP1335908B1 (en)	2008-02-13
CN1479728A (zh)	2004-03-03
JP2004513166A (ja)	2004-04-30
US7304062B2 (en)	2007-12-04
ES2300378T3 (es)	2008-06-16
KR20030048133A (ko)	2003-06-18
WO2002038553A2 (en)	2002-05-16
TW200716572A (en)	2007-05-01

Publication	Publication Date	Title
IL154840A0 (en)	2003-10-31	Peroxisome proliferator activated receptor alpha agonists
IL161578A0 (en)	2004-09-27	Peroxisome proliferator activated receptor agonists
IL156487A0 (en)	2004-01-04	Carbazole derivatives and their use as neuropeptide y5 receptor ligands
IL155634A0 (en)	2003-11-23	3-arylindole derivatives and their use as cb2 receptor agonists
AU2002224138A1 (en)	2002-06-18	Peroxisome proliferator activated receptor d activators
DK1189916T3 (da)	2004-03-22	N-pyrazol A 2A-receptoragonister
IL158873A0 (en)	2004-05-12	Modulators of peroxisome proliferator activated receptors
IL154911A0 (en)	2003-10-31	Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
IL150898A0 (en)	2003-02-12	Novel melanocortin receptor agonists and antagonists
IL152700A0 (en)	2003-06-24	Substituted 1-aminoalkyl-lactams and their use as muscarinc receptor antagonists
AU2002223501A1 (en)	2002-05-27	Glucagon antagonists/inverse agonists
AU775774C (en)	2005-05-19	Peroxisome proliferator-activated receptor agonist
ZA200207489B (en)	2003-12-18	Apomorphine derivatives and methods for their use.
AU2002223500A1 (en)	2002-05-27	Glucagon antagonists/inverse agonists
AU2002347985A1 (en)	2003-06-10	Peroxisome proliferator activated receptor alpha agonists
AU9259801A (en)	2002-03-26	Alpha v integrin receptor antagonists
AU2001290772A1 (en)	2002-03-26	Alpha v integrin receptor antagonists
GB2349882B (en)	2004-08-11	Dopamine transporter imaging agents
GB2355567B (en)	2003-10-29	Fluid multiplexer
AU2090202A (en)	2002-06-18	1, 2, 4-oxadiazole derivatives as hppar alpha agonists
HUP0200057A3 (en)	2004-03-29	Dopamine d1 receptor agonist compounds, pharmaceutical compositions containing them and their use
GB0019412D0 (en)	2000-09-27	New imaging agent
HK1071563A (en)	2005-07-22	Peroxisome proliferator activated receptor agonists
AU9088401A (en)	2002-03-26	Alpha v integrin receptor antagonists
HU9904583D0 (en)	2000-02-28	Alpha light-sound device